Pichl Daniel 4
4 · SpringWorks Therapeutics, Inc. · Filed Feb 20, 2024
Insider Transaction Report
Form 4
Pichl Daniel
Chief People Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-16$27.64/sh+15,000$414,600→ 60,212 total - Sale
Common Stock
2024-02-16$50.10/sh−15,000$751,550→ 45,212 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-16−15,000→ 45,000 totalExercise: $27.64Exp: 2033-01-05→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 9, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]This option shall vest in 48 equal monthly installments subject to continued service to the Issuer by the Reporting Person.